Webinars Overview
Peptide therapeutics offer immense potential but present complex development challenges, particularly in oral formats. This expert-led presentation explores how integrated DMPK, bioanalytical, and toxicology strategies can address barriers to absorption, stability, and safety. With a focus on practical case examples and proven approaches, it highlights how thoughtful study design and cross-functional expertise can streamline development and reduce risk from early studies through clinical advancement.
Learning Objectives:
Understand key DMPK challenges for peptide therapeutics, including absorption barriers and formulation impact.
Explore bioanalytical strategies for accurate peptide quantification, immunogenicity, and metabolite analysis.
Learn how peptide toxicology differs from small molecules and how to design effective safety studies.
Discover how integrated DMPK, bioanalysis, and toxicology approaches streamline development and reduce risk.
Gain insights from real-world case examples to support smarter study design and regulatory readiness.
Related Resources
-
Introduction to Peptide-Drug Conjugates (PDCs) and DMPK Research Strategies
ArticlesAug 13,2026 -
ADME Studies of 37 FDA Approved Peptides: Strategies and Radiolabeling Considerations
ArticlesAug 07,2026 -
Unraveling Peptide Disulfide Bonds via Enzymatic Digestion: A Rapid and Precise Characterization Strategy
ArticlesJul 31,2026
Related Services and Platforms
-
Novel Drug Modalities DMPK Enabling PlatformsLearn More -
PROTAC DMPK ServicesLearn More -
ADC DMPK ServicesLearn More -
Antibody-Oligonucleotide Conjugate (AOC) DMPK ServicesLearn More -
Oligo DMPK ServicesLearn More -
PDC DMPK ServicesLearn More -
Peptide DMPK ServicesLearn More -
mRNA DMPK ServicesLearn More -
Covalent Drugs DMPK ServicesLearn More
Stay Connected
Keep up with the latest news and insights.